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Background 
Transforming Growth Factor-β1 (TGFβ1) induces 
epithelial-to-mesenchymal transition (EMT) in 
alveolar type 2 (ATII) cells in vitro. This process is 
implicated in the pathogenesis of Idiopathic 
Pulmonary Fibrosis (IPF). SMADs are transcription 
factors activated by TGFβ1 signalling. When the 
TGFβ1 signalling pathway is activated, SMAD 
translocates from the cytoplasm to the nucleus. 
Wnt11 is a conserved glycoprotein secreted by 
macrophages and some ATII cells in the adult lung. 
Wnts bind to Frizzled (Fz) receptors. Previous work 
has shown that Wnt11 appears to inhibit both 
spontaneous and TGFβ1-driven EMT in ATII cell 
cultures. 
Aims: To investigate the role of Wnt11 – Frizzled 
receptor signalling on EMT in human ATII cells 
Results 
Wnt11 inhibits expression of mesenchymal markers 
& promotes expression of epithelial markers in cells 
treated with TGFβ1 (data not shown). Wnt11 
inhibits TGFβ1-mediated migration of A549s and 
promotes A549 proliferation. Silencing Fz2 leads to 
increased expression of SMAD. Wnt11 inhibits 
SMAD nuclear translocation. 
 
Methods 
A549 cancer cell lines were used as a model for type II alveolar 
cells. We used 2 types of transgenic A549 cells, created by 
infecting cells with lentivirus vectors A549 cells which stably 
express Wnt11 and GFP A549 cells which stable express GFP 
alone (used as control). A549s were treated with 10ng/ml TGFβ1 
for 24 hours. SiRNAs targeted against mRNA coding for frizzled 
receptors were used to create a temporary “knockdown” effect. 
Epithelial and mesenchymal marker expression was assessed 
using RT-qPCR and FACS. BrdU proliferation assays & wound 
healing assays. Confocal microscopy was used to observe 
intracellular SMAD distribution. 
 
 
 
 
 
 
 
 
 
 
Conclusions 
The Wnt11-Fz2 and TGFβ-SMAD signalling pathways 
appear to be antagonistic, with the Wnt11 pathway 
opposing TGFβ-mediated EMT. Future therapies 
directed at promoting the Wnt11 may potentially be 
used in IPF. 
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